SCHEMBL4467972

SCHEMBL4467972

Cc1cc(CC2(N)N=C(N)C=CN2)on1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
VHL P40337 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4466158 0.79 VHL (0.34) VHLMEN1KMT2AALDH1A1
SCHEMBL4471687 0.70 IGF1R (0.38) MEN1KMT2A
Hydrochloric Acid SCHEMBL2120996 0.61
SCHEMBL805042 0.60
SCHEMBL803419 0.60 MEN1 (0.46) VHLMEN1KMT2AALDH1A1
SCHEMBL933778 0.59
SCHEMBL513694 0.59 MEN1 (0.48) VHLMEN1KMT2AALDH1A1
SCHEMBL2093209 0.59
SCHEMBL22792608 0.59
SCHEMBL15200484 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed